Hydravex 2 g/100g
Hydravex · GEL · Oncora Pharma, LLC
Hydravex is a gel containing hydravex at 2 g/100g, taken topical. Manufactured by Oncora Pharma, LLC.
Key Facts
- Brand Name
- Hydravex
- Generic Name
- Hydravex
- NDC Code (Product)
85477-310- Manufacturer
- Oncora Pharma, LLC
- Strength
- 2 g/100g
- Dosage Form
- GEL
- Route
- TOPICAL
- Marketing Status
- Drug Class
- Corticosteroid [EPC]
- Marketing Start
- 04/01/2025
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatosis.
Dosage & Administration
DOSAGE AND ADMINISTRATION Topical corticosteroids are generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
Warnings
WARNINGS: For external use only. Not for ophthalmic use. PRECAUTIONS General Systemic absorption of topical corticosteroids has produced reversible hypothalamicpituitary- adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria in some patients. Conditions which augment systemic absorption include the application of the more potent steroids, use over large surface areas, prolonged use, and the addition of occlusive dressings. Therefore, patients receiving a large dose of a potent topical steroid applied to a large surface area or under an occlusive dressing should be evaluated periodically for evidence of HPA axis suppression by using the urinary free cortisol and ACTH stimulation tests. If HPA axis suppression is noted, an attempt should be made to withdraw the drug, to reduce the frequency of application, or to substitute a less potent steroid. Recovery of HPA axis function is generally prompt and complete upon discontinuation of the drug. Infrequently, signs and symptoms of steroid withdrawal may occur, requiring supplemental systemic corticosteroids. Children may absorb proportionally larger amounts of topical corticosteroids and thus …
Contraindications
CONTRAINDICATIONS Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Adverse Reactions
ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.
Frequently Asked Questions
What is Hydravex used for?
Hydravex contains Hydravex. It is a gel taken topical. Consult your doctor for specific uses.
Is Hydravex a controlled substance?
Hydravex is not classified as a controlled substance by the DEA.
What is the generic name for Hydravex?
The generic name for Hydravex is Hydravex. There are no other listed brand versions of Hydravex.
What is the NDC code for Hydravex 2 g/100g?
The NDC (National Drug Code) for Hydravex 2 g/100g is 85477-310, listed by Oncora Pharma, LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)